Single User License
INR 96000
Site License
INR 192000
Corporate User License
INR 288000

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

ThromboGenics NV-Product Pipeline Review-2015

ThromboGenics NV-Product Pipeline Review-2015

  • Products Id :- GMDHC07238CDB
  • |
  • Pages: 33
  • |
  • June 2015
  • |
  • |
  Request for Sample Report

Executive Summary

ThromboGenics NV-Product Pipeline Review-2015


Global Markets Direct's, 'ThromboGenics NV-Product Pipeline Review-2015', provides an overview of the ThromboGenics NV's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ThromboGenics NV's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of ThromboGenics NV including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of ThromboGenics NV's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the ThromboGenics NV's pipeline products

Reasons To Buy

Evaluate ThromboGenics NV's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of ThromboGenics NV in its therapy areas of focus

Identify new drug targets and therapeutic classes in the ThromboGenics NV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of ThromboGenics NV and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of ThromboGenics NV

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of ThromboGenics NV and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

ThromboGenics NV Snapshot 5

ThromboGenics NV Overview 5

Key Information 5

Key Facts 5

ThromboGenics NV-Research and Development Overview 6

Key Therapeutic Areas 6

ThromboGenics NV-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Out-Licensed Products 10

Out-Licensed Products/Combination Treatment Modalities 11

ThromboGenics NV-Pipeline Products Glance 12

ThromboGenics NV-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

ThromboGenics NV-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

ThromboGenics NV-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

ThromboGenics NV-Drug Profiles 16

ocriplasmin (recombinant) 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

TG-758 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

TG-931 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

ThromboGenics NV-Pipeline Analysis 21

ThromboGenics NV-Pipeline Products by Target 21

ThromboGenics NV-Pipeline Products by Route of Administration 22

ThromboGenics NV-Pipeline Products by Molecule Type 23

ThromboGenics NV-Pipeline Products by Mechanism of Action 24

ThromboGenics NV-Recent Pipeline Updates 25

ThromboGenics NV-Dormant Projects 30

ThromboGenics NV-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Appendix 32

Methodology 32

Coverage 32

Secondary Research 32

Primary Research 32

Expert Panel Validation 32

Contact Us 32

Disclaimer 33

List of Tables

ThromboGenics NV, Key Information 5

ThromboGenics NV, Key Facts 5

ThromboGenics NV-Pipeline by Indication, 2015 7

ThromboGenics NV-Pipeline by Stage of Development, 2015 8

ThromboGenics NV-Monotherapy Products in Pipeline, 2015 9

ThromboGenics NV-Out-Licensed Products in Pipeline, 2015 10

ThromboGenics NV-Out-Licensed Products/ Combination Treatment Modalities, 2015 11

ThromboGenics NV-Phase III, 2015 12

ThromboGenics NV-Phase II, 2015 13

ThromboGenics NV-Phase I, 2015 14

ThromboGenics NV-Preclinical, 2015 15

ThromboGenics NV-Pipeline by Target, 2015 21

ThromboGenics NV-Pipeline by Route of Administration, 2015 22

ThromboGenics NV-Pipeline by Molecule Type, 2015 23

ThromboGenics NV-Pipeline Products by Mechanism of Action, 2015 24

ThromboGenics NV-Recent Pipeline Updates, 2015 25

ThromboGenics NV-Dormant Developmental Projects,2015 30

ThromboGenics NV, Other Locations 31

ThromboGenics NV, Subsidiaries 31

List of Figures

ThromboGenics NV-Pipeline by Top 10 Indication, 2015 7

ThromboGenics NV-Pipeline by Stage of Development, 2015 8

ThromboGenics NV-Monotherapy Products in Pipeline, 2015 9

ThromboGenics NV-Pipeline by Top 10 Target, 2015 21

ThromboGenics NV-Pipeline by Top 10 Route of Administration, 2015 22

ThromboGenics NV-Pipeline by Top 10 Molecule Type, 2015 23

ThromboGenics NV-Pipeline Products by Top 10 Mechanism of Action, 2015 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of ThromboGenics NV; ThromboGenics NV - Key Therapeutics; ThromboGenics NV - Pipeline Overview and Promising Molecules; ThromboGenics NV - News; ThromboGenics NV - Latest Updates; ThromboGenics NV - Pipeline; ThromboGenics NV - Discontinued/Dormant Projects

Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]